Sesen Bio Announces New Appointments to its Board of Directors

Magenta Therapeutics Announces Update On U.S. FDA Investigational New Drug Application For MGTA-117 In Patients With Acute Myeloid Leukemia And Myelodysplastic Syndrome

Sesen Bio and Qilu Pharmaceutical Announce Enrollment of First Patient in Clinical Trial for Vicineum™ in China

Jounce Therapeutics to Participate in William Blair’s Biotech Focus Conference

Magenta Therapeutics Appoints Caren Deardorf As Chief Commercial Officer